The participants of the 72nd session of the World Health Assembly today adopted a resolution, the authors of which call for an increase in the transparency of the market for drugs, vaccines and other pharmaceutical products. Its main goal is to ensure the protection of public health and to make medicines available for more people.
In the document, the member states of the World Health Organization (WHO) are asked to publish information about the prices at which the government and other parties are purchasing drugs, as well as patents, clinical trials and other factors that affect the pricing of such products.
In accordance with the resolution, the WHO Secretariat should contribute to increasing the transparency of the markets and providing the population with affordable medicines. The World Health Organization will also help states to make thoughtful decisions when purchasing medicines and negotiate more affordable prices.
The World Health Assembly is the highest decision-making body of WHO. The annual 72nd session of the World Assembly ended today in Geneva. WHO believes that every inhabitant of the planet should be able to see a doctor and get qualified help. Obviously, access to medicines is one of the key components of such a system.